SU
INSIDER · BNTX · BioNTech SE · CHIEF EXECUTIVE OFFICER
Sahin Ugur
Every open-market transaction filed under this name, Sep 3 to Oct 9.
Filings
26
0 buys · 26 sells
Bought
—
open market, at cost
Sold
$84.2M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 9 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 36,209 | $95.37 | $3.5M | −8.0% |
| Oct 8 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 27,000 | $92.31 | $2.5M | −5.0% |
| Oct 7 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 24,000 | $95.86 | $2.3M | −8.5% |
| Oct 6 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 21,000 | $96.81 | $2M | −9.4% |
| Oct 5 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 72,000 | $97.23 | $7M | −9.8% |
| Oct 2 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 17,000 | $96.72 | $1.6M | −9.3% |
| Oct 1 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 17,000 | $97.46 | $1.7M | −10.0% |
| Sep 30 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 32,000 | $98.12 | $3.1M | −10.6% |
| Sep 29 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 34,000 | $98.26 | $3.3M | −10.7% |
| Sep 28 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 34,000 | $98.47 | $3.3M | −10.9% |
| Sep 25 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 27,000 | $98.69 | $2.7M | −11.1% |
| Sep 24 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 39,000 | $98.99 | $3.9M | −11.4% |
| Sep 23 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 30,000 | $99.40 | $3M | −11.8% |
| Sep 22 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 46,000 | $100.72 | $4.6M | −12.9% |
| Sep 21 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 33,000 | $97.81 | $3.2M | −10.3% |
| Sep 18 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 30,000 | $96.22 | $2.9M | −8.8% |
| Sep 17 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 34,000 | $98.60 | $3.4M | −11.0% |
| Sep 16 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 15,000 | $96.09 | $1.4M | −8.7% |
| Sep 15 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 34,000 | $96.49 | $3.3M | −9.1% |
| Sep 14 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 41,000 | $99.45 | $4.1M | −11.8% |
| Sep 11 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 45,000 | $96.93 | $4.4M | −9.5% |
| Sep 10 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 20,500 | $96.31 | $2M | −8.9% |
| Sep 9 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 36,000 | $97.78 | $3.5M | −10.3% |
| Sep 8 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 37,000 | $99.20 | $3.7M | −11.6% |
| Sep 4 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 31,500 | $103.52 | $3.3M | −15.3% |
| Sep 3 | BNTX | BioNTech SE | Chief Executive Officer | Sell | 45,000 | $102.85 | $4.6M | −14.7% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.